The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
Open accessAbstract
Drug development has a high attrition rate, with poor pharmacokinetic and safety properties a significant hurdle. Computational approaches may help minimize these risks. We have developed a novel approach (pkCSM) which uses graph-based signatures to develop predictive models of central ADMET properties for drug development. pkCSM performs as well or better than current methods. A freely accessible web server (http://structure.bioc.cam.ac.uk/pkcsm), which retains no information submitted to it, provides an integrated platform to rapidly evaluate pharmacokinetic and toxicity properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties
Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300367a · Cited by 2,222
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
mCSM: Predicting the effects of mutations in proteins using graph-based signatures
Pires, D. E. V., Ascher, D. B., & Blundell, T. L. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt691 · Cited by 1,066
Self-citationEfficient Algorithms for Shortest Paths in Sparse Networks
Johnson, D. B. (1977) · Journal of the ACM · doi:10.1145/321992.321993 · Cited by 1,041
Physiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 946
Pires, D. E. V., Ascher, D. B., & Blundell, T. L. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku411 · Cited by 932
Self-citationPegylation: A Novel Process for Modifying Pharmacokinetics
Harris, J. M., Martin, N. E., & Modi, M. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00005 · Cited by 913
ProTox: a web server for the in silico prediction of rodent oral toxicity
Drwal, M. N., Banerjee, P., Dunkel, M., Wettig, M. R., & Preissner, R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku401 · Cited by 738
Derivation and Validation of Toxicophores for Mutagenicity Prediction
Kazius, J., McGuire, R., & Bursi, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040835a · Cited by 666
Screening for human ADME/Tox drug properties in drug discovery
Li, A. P. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01712-3 · Cited by 536
An evaluation of the implementation of the Cramer classification scheme in the Toxtree software
Patlewicz, G., Jeliazkova, N., Safford, R. J., Worth, A. P., & Aleksiev, B. (2008) · SAR and QSAR in Environmental Research · doi:10.1080/10629360802083871 · Cited by 512
Obach, R. S., Lombardo, F., & Waters, N. J. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020479 · Cited by 462
Drug discovery beyond the ‘rule-of-five’
Zhang, M.-Q., & Wilkinson, B. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.005 · Cited by 418
Estimation of ADME Properties with Substructure Pattern Recognition
Shen, J., Cheng, F., Xu, Y., Li, W., & Tang, Y. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100104j · Cited by 349
The Role of Absorption, Distribution, Metabolism, Excretion and Toxicity in Drug Discovery
Lin, J., Sahakian, D., de Morais, S., Xu, J., Polzer, R., & Winter, S. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452096 · Cited by 327
Chemical predictive modelling to improve compound quality
Cumming, J. G., Davis, A. M., Muresan, S., Haeberlein, M., & Chen, H. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4128 · Cited by 311
Toward in silico structure-based ADMET prediction in drug discovery
Moroy, G., Martiny, V. Y., Vayer, P., Villoutreix, B. O., & Miteva, M. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.023 · Cited by 302
ADME/PK as part of a rational approach to drug discovery
Eddershaw, P. J., Beresford, A. P., & Bayliss, M. K. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01540-3 · Cited by 237
Hou, T., Wang, J., Zhang, W., & Xu, X. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600343x · Cited by 228
Gaussian Processes: A Method for Automatic QSAR Modeling of ADME Properties
Obrezanova, O., Csányi, G., Gola, J. M. R., & Segall, M. D. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci7000633 · Cited by 213
Classification of Cytochrome P450 Inhibitors and Noninhibitors Using Combined Classifiers
Cheng, F., Yu, Y., Shen, J., Yang, L., Li, W., Liu, G., Lee, P. W., & Tang, Y. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200028n · Cited by 196
A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields
Broccatelli, F., Carosati, E., Neri, A., Frosini, M., Goracci, L., Oprea, T. I., & Cruciani, G. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101421d · Cited by 176
Multi-dimensional QSAR in drug discovery
Lill, M. A. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.08.004 · Cited by 174
T3DB: a comprehensively annotated database of common toxins and their targets
Lim, E., Pon, A., Djoumbou, Y., Knox, C., Shrivastava, S., Guo, A. C., Neveu, V., & Wishart, D. S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp934 · Cited by 168
Fourches, D., Barnes, J. C., Day, N. C., Bradley, P., Reed, J. Z., & Tropsha, A. (2010) · Chemical Research in Toxicology · doi:10.1021/tx900326k · Cited by 162 · cited 1×
“Fluorine atom Count Integer Toxicophore [1-36]c Binary vector Pharmacophore countd Integer vector a Topological polar surface area(23).”
BackgroundComputational toxicology—a tool for early safety evaluation
Merlot, C. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.010 · Cited by 156
FAF-Drugs: free ADME/tox filtering of compound collections
Miteva, M. A., Violas, S., Montès, M., Gomez, D. A., Tufféry, P., & Villoutreix, B. O. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl065 · Cited by 139
Computational Prediction of Blood-Brain Barrier Permeability Using Decision Tree Induction
Suenderhauf, C., Hammann, F., & Huwyler, J. (2012) · Molecules · doi:10.3390/molecules170910429 · Cited by 132
Khan, M. T. H. (2010) · Current Drug Metabolism · doi:10.2174/138920010791514306 · Cited by 127
Alves, V. M., Muratov, E. N., Fourches, D., Strickland, J. A., Kleinstreuer, N., Andrade, C. H., & Tropsha, A. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.12.014 · Cited by 120
In Silico Assessment of Chemical Biodegradability
Cheng, F., Ikenaga, Y., Zhou, Y., Yu, Y. S., Li, W., Shen, J., Du, Z., Chen, L., Xu, C., Liu, G., et al. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200622d · Cited by 117
da Silveira, C. H., Pires, D. E. V., de Melo-Minardi, R. C., Ribeiro, C. O., Veloso, C. J. M., Lopes, J. C. D., Meira, W., Neshich, G., Ramos, C. H. I., Habesch, R., et al. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22187 · Cited by 111
Self-citationEarly ADME in Support of Drug Discovery: The Role of Metabolic Stability Studies
Thompson, T. N. (2000) · Current Drug Metabolism · doi:10.2174/1389200003339018 · Cited by 106
Cao, D., Wang, J., Zhou, R., Li, Y., Yu, H., & Hou, T. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300112j · Cited by 105
Cheng, F., Shen, J., Yu, Y. S., Li, W., Liu, G., Lee, P. W., & Tang, Y. (2010) · Chemosphere · doi:10.1016/j.chemosphere.2010.11.043 · Cited by 104
Pires, D. E. V., de Melo-Minardi, R. C., dos Santos, M. A., da Silveira, C. H., Santoro, M. M., & Meira, W. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-s4-s12 · Cited by 104
Self-citationNemethova, M., Radvánszky, J., Kádaši, Ľ., Ascher, D. B., Pires, D. E. V., Blundell, T. L., Porfirio, B., Mannoni, A., Santucci, A., Millucci, L., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.60 · Cited by 102
Self-citationSuperToxic: a comprehensive database of toxic compounds
Schmidt, U., Struck, S., Grüning, B. A., Hossbach, J., Jaeger, I. S., Parol, R., Lindequist, U., Teuscher, E., & Preißner, R. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn850 · Cited by 100
Yap, C. W., Li, Z., & Chen, Y. (2005) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2005.10.004 · Cited by 99
Berellini, G., Springer, C., Waters, N. J., & Lombardo, F. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9004658 · Cited by 92
Alves, V. M., Muratov, E. N., Fourches, D., Strickland, J. A., Kleinstreuer, N., Andrade, C. H., & Tropsha, A. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.12.013 · Cited by 92
Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku966 · Cited by 91
Self-citationPK/DB: database for pharmacokinetic properties and predictive in silico ADME models
Moda, T. L., Torres, L. G., Carrara, A. E., et al. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn415 · Cited by 89
Insights into Molecular Basis of Cytochrome P450 Inhibitory Promiscuity of Compounds
Cheng, F., Yu, Y., Zhou, Y., Shen, Z., Xiao, W. J., Liu, G., Li, W., Lee, P. W., & Tang, Y. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200317s · Cited by 87
Matthews, E. J., Kruhlak, N. L., Benz, R., & Contrera, J. F. (2004) · Current Drug Discovery Technologies · doi:10.2174/1570163043484789 · Cited by 85
Kaminskas, L. M., Ascher, D. B., McLeod, V. M., Herold, M. J., Le, C. P., Sloan, E. K., & Porter, C. J. H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.006 · Cited by 73
Self-citationaCSM: noise-free graph-based signatures to large-scale receptor-based ligand prediction
Pires, D. E. V., de Melo-Minardi, R. C., da Silveira, C. H., Campos, F. F., & Meira, W. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt058 · Cited by 71
Self-citationFröhlich, H., Wegner, J. K., Sieker, F., & Zell, A. (2006) · QSAR & Combinatorial Science · doi:10.1002/qsar.200510135 · Cited by 66
Modeling Oral Rat Chronic Toxicity
Mazzatorta, P., Estévez, M. D., Coulet, M., & Schilter, B. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci8001974 · Cited by 61
Usher, J. L., Ascher, D. B., Pires, D. E. V., Milan, A. M., Blundell, T. L., & Ranganath, L. R. (2014) · JIMD Reports · doi:10.1007/8904_2014_380 · Cited by 56
Self-citationKaminskas, L. M., McLeod, V. M., Ascher, D. B., Ryan, G. M., Jones, S. A., Haynes, J. M., Trevaskis, N. L., Chan, L. J., Sloan, E. K., Finnin, B. A., et al. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500531e · Cited by 55
Self-citationGraph Kernels for Molecular Similarity
Rupp, M., & Schneider, G. (2010) · Molecular Informatics · doi:10.1002/minf.200900080 · Cited by 49
Liu, R., Tawa, G. J., & Wallqvist, A. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300279f · Cited by 48
Chan, L. J., Bulitta, J. B., Ascher, D. B., Haynes, J. M., McLeod, V. M., Porter, C. J. H., Williams, C. C., & Kaminskas, L. M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5006189 · Cited by 40
Self-citationA critical assessment of modeling safety-related drug attrition
Muthas, D., Boyer, S. K., & Hasselgren, C. (2013) · MedChemComm · doi:10.1039/c3md00072a · Cited by 39
del Amo, E. M., Ghemtio, L., Xhaard, H., Yliperttula, M. L., Urtti, A. O., & Kidron, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074758 · Cited by 35
FragmentStore--a comprehensive database of fragments linking metabolites, toxic molecules and drugs
Ahmed, J., Worth, C. L., Thaben, P. F., Matzig, C., Blasse, C., Dunkel, M., & Preißner, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq969 · Cited by 34
ADME-AP: a database of ADME associated proteins
Sun, L., Zhang, J., Chen, X., et al. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.12.1699 · Cited by 31
Landersdorfer, C. B., Caliph, S. M., Shackleford, D. M., Ascher, D. B., & Kaminskas, L. M. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24412 · Cited by 8
Self-citation
Cited by
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., Hsieh, C., Yin, M., Zeng, X., Wu, C., Lu, A., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab255 · Cited by 2,857
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Dong, J., Wang, N.-N., Yao, Z.-J., Zhang, L., Cheng, Y., Ouyang, D., Lu, A.-P., & Cao, D.-S. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0283-x · Cited by 889
Metadata
- Authors
- Pires, D. E. V., Blundell, T. L., & Ascher, D. B.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-04-22
- Volume
- 58
- Issue
- 9
- Pages
- 4066-4072
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2009867031
- Cited by
- 5,716
- References
- 63
- FWCI
- 38.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.